Taylor Farms disputes FDA's link to cyclospora outbreak

In the United States, Taylor Farms has faced scrutiny over foodborne illness outbreaks and recalls over the past 17 years, involving pathogens such as salmonella, E. coli, and cyclospora. The company has been linked to several significant outbreaks, including a 2009 salmonella outbreak associated with shredded lettuce that sickened 145 people in the western U.S. and Canada, and a 2013 cyclospora outbreak tied to bagged salad mix that affected 631 individuals across 25 states. Despite these incidents, no recalls were issued in these cases, and Taylor Farms has consistently disputed claims connecting its products to these illnesses.

In 2026, a cyclospora outbreak traced to shredded iceberg lettuce supplied by Taylor Farms de Mexico resulted in 6,358 confirmed cases across 15 states. The FDA conducted an investigation and maintained confidence in its findings, asserting that the evidence linked the outbreak to the lettuce supplied by Taylor Farms. However, the company has rejected this conclusion, labeling it a "false positive" and arguing that the evidence does not conclusively establish its products as the source of the outbreak. This ongoing dispute highlights the complexities of food safety investigations and the challenges faced by companies in the fresh produce industry.

Additionally, in August 2026, Taylor Farms announced a recall of prepared foods containing jalapeño peppers after a supplier recalled fresh jalapeños due to potential salmonella contamination. While federal and state health officials were investigating a multistate salmonella outbreak linked to these peppers, Taylor Farms stated it was not aware of any illnesses connected to its products at the time of the recall. The company has emphasized its commitment to food safety and cooperation with regulatory agencies in addressing any concerns.

The timeline of outbreaks and recalls associated with Taylor Farms raises questions about the effectiveness of food safety measures and the accountability of food suppliers. As the company continues to navigate these challenges, it remains to be seen how public perception and regulatory scrutiny will evolve in response to its past incidents and ongoing disputes with health authorities.